Skyviews Life Science logo

Skyviews Life Science

Venture Capital

Skyviews identifies investment opportunities in precision health and longevity.

8 employees Health Care

13

Total Investments

10

Portfolio Companies

-

Exits

1

Industries

General Information

Industries Health Care

Company Overview

Employees 8
Location -

Investment Criteria

Investment Thesis

•••••• •••••• ••••••

About Skyviews Life Science

Skyviews is a privately held advisory company specialised in precision health and longevity. We identify investment opportunities at the growing interface between biotechnology, advanced nutrition and digital health. We target private and public companies with better drugs, advanced technology platforms, preventive strategies, personalized solutions and more natural foods that will improve people’s quality of life. We are a team of experienced professionals from the academic, corporate, consumer and venture capital sectors. We leverage worldwide networks and work closely with partner organizations to identify outstanding value for our clients, for patients, for healthcare payors and for capital. Our perspective is rooted in “P4 medicine”, evolving from reactive disease care to care that is predictive, preventive, personalized and participatory. This new paradigm focuses on big data, better lifestyles and tailored treatments, building on the evidence that each individual’s health experience is unique.

Recent Investments (13)

View All
Company Stage Amount Date
Post Ipo Equity •••••• Feb 2023
Series A •••••• Oct 2022
Series C •••••• Jul 2022
Series A •••••• Apr 2022
Series D •••••• Jul 2021
Portfolio company •••• ••••
Series B •••••• May 2021
Portfolio company •••• ••••
Seed Round •••••• Mar 2021
Portfolio company •••• ••••
Series B •••••• Jan 2021
Portfolio company •••• ••••
Series B •••••• Dec 2020
Portfolio company •••• ••••
Series B •••••• Jun 2020

See all 13 investments →

All startup & investor data, one platform.

Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.

Access Millions of Companies and 50K+ Investors

Signal-based outbound intelligence for sales, agencies, and investors.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes